Australia
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 540.80 M
|
June 30, 2024 | USD 21.85 | 0.51% |
|
Australia |
|
2 |
USD 243.73 M
|
June 30, 2024 | NA |
|
Australia |
||
3 |
USD 0.00
|
June 30, 2024 | USD 1.67 | 2.45% |
|
Australia |
|
4 |
USD -2.38 M
|
June 30, 2024 | USD 7.25 | -0.16% |
|
Australia |
|
5 |
USD -7.53 M
|
June 30, 2024 | USD 3.05 | 0.43% |
|
Australia |
|
6 |
USD -11.82 M
|
June 30, 2024 | USD 0.77 | -1.58% |
|
Australia |
|
7 |
USD -12.67 M
|
June 30, 2024 | USD 1.01 | -0.60% |
|
Australia |
|
8 |
USD -13.24 M
|
June 30, 2024 | USD 2.92 | 0.89% |
|
Australia |
|
9 |
USD -26.42 M
|
June 30, 2024 | USD 2.07 | 4.12% |
|
Australia |
|
10 |
USD -35.39 M
|
Dec. 31, 2023 | USD 5.29 | -0.81% |
|
Australia |
|
11 |
USD -110.12 M
|
June 30, 2024 | USD 18.03 | 1.39% |
|
Australia |
|
12 |
USD -142.49 M
|
June 30, 2024 | USD 1.35 | 0.48% |
|
Australia |
|
13 |
USD -243.88 M
|
July 31, 2024 | USD 15.28 | 0.26% |
|
Australia |
The Eyewear company in Australia with the highest Net Cash Used Provided By Financing Activities is Ansell Limited (ASX: ANN.AX) at USD 540.80 M.
The Eyewear company in Australia with the lowest Net Cash Used Provided By Financing Activities is Premier Investments Limited (ASX: PMV.AX) at USD -243.88 M.
The top 10 Eyewear companies in Australia by Net Cash Used Provided By Financing Activities are Ansell Limited, Opthea Limited, Incannex Healthcare Limited, Clinuvel Pharmaceuticals Limited, IPH Limited, Step One Clothing Limited, Lynch Group Holdings Limited, Mayne Pharma Group Limited, Beacon Lighting Group Limited and Dicker Data Limited.
The bottom 10 Eyewear companies in Australia by Net Cash Used Provided By Financing Activities are Premier Investments Limited, Accent Group Limited, Lovisa Holdings Limited, Dicker Data Limited, Beacon Lighting Group Limited, Mayne Pharma Group Limited, Lynch Group Holdings Limited, Step One Clothing Limited, IPH Limited and Clinuvel Pharmaceuticals Limited.